Changes in invasive pneumococcal disease among adults living with HIV following introduction of 13-valent pneumococcal conjugate vaccine, 2008–2014

نویسندگان

  • Miwako Kobayashi
  • William Adih
  • Jianmin Li
  • Ryan Gierke
  • Olivia M Almendares
  • James Watt
  • Nisha Alden
  • Susan Petit
  • Monica Farley
  • Lee Harrison
  • Ruth Lynfield
  • Joan Baumbach
  • Ann Thomas
  • William Schaffner
  • Tamara Pilishvili
چکیده

Miwako Kobayashi, Centers for Disease Control and Prevention William Adih, Centers for Disease Control and Prevention Jianmin Li, Centers for Disease Control and Prevention Ryan Gierke, Centers for Disease Control and Prevention Olivia M. Almendares, Centers for Disease Control and Prevention James Watt, California Department of Public Health Nisha Alden, Colorado Department of Public Health and Environment Susan Petit, Connecticut Emerging Infections Program Monica Farley, Emory University Lee Harrison, University of Pittsburgh

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.

CONTEXT A conjugate vaccine targeting 7 pneumococcal serotypes was licensed for young children in 2000. In contrast to the 23-valent polysaccharide vaccine used in adults, the 7-valent conjugate vaccine affects pneumococcal carriage and transmission. Early after its introduction, incidence of invasive pneumococcal disease declined among older adults, a group at high risk for pneumococcal diseas...

متن کامل

Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study

Background: Pneumococcal vaccine provides protection against invasive pneumococcal disease in population at risk. This study was conducted to compare the antibody response to 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in patients with thalassemia major. Methods: A randomized cross-over clinical trial was performed on 50 asplenic patients with t...

متن کامل

Pitfalls in case-control studies of vaccine effectiveness.

1. Barricarte A, Castilla J, Gil-Setas A, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study. Clin Infect Dis 2007; 44:1436–41. 2. Grimes DA, Schutlz KF. Bias and causal associations in observational research. Lancet 2002; 359:248–52. 3. Bland JM, Altman DG. Matching. BMJ 1994; 309:1128. 4. Barricarte A, Gil-Setas A, Torroba A, et al. Inva...

متن کامل

Pneumococcal Serotypes and Serogroups Causing Invasive Disease in Pakistan, 2005–2013

While pneumococcal conjugate vaccines have been implemented in most countries worldwide, use in Asia has lagged in part because of a lack of data on the amount of disease that is vaccine preventable in the region. We describe pneumococcal serotypes elicited from 111 episodes of invasive pneumococcal disease (IPD) from 2005 to 2013 among children and adults in Pakistan. Seventy-three percent (n ...

متن کامل

Role of Pneumococcal Vaccine in HIV Infected Population.

1Senior Consultant, Institute of Infectious Diseases, Apollo Hospitals, Chennai; Adjunct Professor, Tamil Nadu Dr. MGR Medical University; Adjunct Associate Professor, Apollo Hospitals Educational and Research Foundation. S v e r e a n d r e c u r r e n t pneumococcal disease is more common with HIV infect ion. 13 Adults infected with human immunodeficiency virus (HIV) are at high risk for Stre...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 4  شماره 

صفحات  -

تاریخ انتشار 2017